$2.38, thank you. Too many retail investors listening to AFR/PWC on things they should have already known. Expect far less cash burn with trials having been completed and now onto some nice partnerships and well funded trials.
This is a specialist orthopedic fund who clearly recognises the science, mechanisms of treatment and huge potential of MSB. I was only explaining their CLBP trials/results to a mate with DDD and a good understanding of the pathology and he was mesmerized as no doubt many informed investors like these guys are by the prospects.
$2.38, thank you. Too many retail investors listening to AFR/PWC...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.07 |
Change
0.043(4.13%) |
Mkt cap ! $1.230B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.09 | $1.03 | $3.630M | 3.401M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 28891 | $1.07 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.08 | 93469 | 14 |
View Market Depth
| Last trade - 12.23pm 02/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |